Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
After having reviewed the conditions of use of an antimycotic-corticoid combination, the authors are reporting their clinical results on 183 patients of a new drug combining econazole and triamcinolon. This clinical trial demonstrates that the own activity of each component of the combination is entirely maintained, and that the new combination shows an original interest in the treatment of all inflammatory dermatomycoses, as well as inflammatory supra-infected dermatoses.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on